In the sensitivity analysis adjusted for clinically significant and sociodemographic variables (Figure; eTable 5 in Supplement 1), Black patients with ovarian cancer remained less likely to have an elevated CA-125 level at diagnosis (AOR, 0.72; 95% CI, 0.68-0.76) compared with White patients. This evidence concerns the gene MUC16 and ovarian cancer.